Impact of Motor and Oral Motor Function on Quality of Life in Children With SMA

CompletedOBSERVATIONAL
Enrollment

23

Participants

Timeline

Start Date

May 30, 2024

Primary Completion Date

June 15, 2024

Study Completion Date

August 30, 2024

Conditions
Spinal Muscular Atrophy Type I
Interventions
OTHER

Neuro-sensory Motor Developmental Assessment

The test used to assess children's development levels evaluates the child's development in six parameters: gross motor function, fine motor function, neurological status, infant movement patterns, postural development and sensory-motor function (tactile, proprioceptive, ocular and vestibular systems) on a scale of 1 to 5. High scores are interpreted as motor dysfunction.

OTHER

Functional Oral Intake Scale

It is a scale consisting of a total of 7 levels and two sections, developed by Crary et al. to indicate the functional oral intake of patients with dysphagia. A higher score indicates a better nutritional level.

OTHER

Behavioral Pediatrics Feeding Assessment Scale

The scale used to determine eating problems in children evaluates both the child's nutritional status and the parents' feelings about the child's nutritional status. It consists of 35 items in total and is scored from 1 to 5. High scores indicate problematic eating behaviors and habits.

OTHER

Pediatric Quality of Life Inventory

The PedsQL assesses health-related quality of life in children ages 2 to 18 years with chronic illnesses from both the child's and parents' perspectives. It consists of 25 items and 3 categories (About My Child's Neuromuscular Disease, Communication, About Our Family Resources). The Neuromuscular Module was used to assess the quality of life of the children in our study and was answered by the parents only. The scale is scored from 0 to 4, with higher scores indicating better quality of life.

Trial Locations (1)

34010

Biruni University, Istanbul

All Listed Sponsors
lead

Zeynep HOŞBAY

OTHER

NCT06864767 - Impact of Motor and Oral Motor Function on Quality of Life in Children With SMA | Biotech Hunter | Biotech Hunter